Search

Steven M. Larson, MD, is an Emeritus Member of the Molecular Imaging and Therapy Service of the Department of Radiology and of the Endocrinology Service, Division of Subspecialty Medicine, of the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK).

… Job Title Emeritus Steven M. Larson, MD, is an Emeritus Member of the Molecular Imaging and Therapy Service of the Department of Radiology and of the Endocrinology Service, Division of Subspecialty Medicine, of the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK). Over the past

The Zallen laboratory focuses on the generation of tissue structure through the collective action of cell populations.

… Our lab focuses on the generation of tissue structure through the collective action of cell populations. During development, many features of tissue and body form are shaped by the reorganization of cell populations, where by individual cells coordinate their movements to produce a global change in tissue

… Full Title A Phase 3, multicenter, double-blind, randomized, placebo-controlled study of ivosidenib in participants >/= 18 years of age with locally advanced or metastatic conventional chondrosarcoma with an IDH1 mutation, untreated or previously treated with 1 or 2 systemic treatment regimens (CHONQUER

… Job Title Postdoctoral Research Fellow Education PhD, Stanford University Degree PhD Start Year 2015 End Year 2022 Publications   First Author Publications Yewdell, W. T. , Smolkin, R. M., Belcheva, K. T., Mendoza, A., Michaels, A. J., Cols, M., Angeletti, D., Yewdell, J. W., & Chaudhuri, J. (2021).

In a recently published paper MSK's Jun Mao explores the global challenges of cancer control and the current status of integrative oncology, offering recommendations to improve access to safe, effective, evidence-based, and culturally sensitive cancer care.

… Thursday, November 18, 2021 Cancer is a global health challenge that impacts countries large and small, affluent and impoverished. With population growth and aging, and success in the management of other acute and chronic diseases, the number of new cancer cases is expected to rise over the next two

… Full Title A Phase 1/2 Study of Combination Lorlatinib and Ramucirumab in Patients with Advanced ALK-rearranged Lung Cancers Purpose Researchers want to find the best dose of lorlatinib to give with ramucirumab in people with lung cancer. They are also seeing how well this drug combination works. The

Memorial Sloan Kettering Cancer Center is using several social media platforms to engage in a dialogue with individuals and organizations who are interested in cancer care, research, and education. To make sure the conversation stays positive and engaging, we have established a comment policy for users who interact with us.

… Memorial Sloan Kettering Cancer Center is active in several social media platforms, including  Facebook ,  Twitter ,  Instagram, YouTube , and  blogs . Through social media, we hope to engage in an ongoing dialogue with individuals and organizations who are interested in cancer care, research, and education

… Job Title Research Project Associate Email [email protected]

… Job Title Research Technician